Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Sanofi

Status and phase: Completed; Phase 4

Conditions: Diabetes Mellitus

Treatments: Drug: GLIMEPIRIDE

Study type: Interventional

Funder types: Industry

Identifiers

NCT00633425

HOE490B_4001

Details and patient eligibility

About

Analyse the glucose profile, based on continuous glucose monitoring by CGMS, in type 2 diabetics inadequately controlled by metformin, before and after the addition of Glimepiride.

Enrollment: 43 patients

Sex: All

Ages: 35 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Men or women aged 35 to 70 years
• Having given their consent
• Type 2 diabetics (HBA1c greater than 6.5%
• Fasting glycaemia greater than 1.40 g/l) not controlled by Metformin for at least 6 weeks.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)